Neurostimulation Devices Market Analysis

1
Neurostimulation Devices Market Analysis by
Product, Application Type (Pain Management,
Epilepsy, Essential Tremor, Urinary and Fecal
Incontinence, Depression, Dystonia,
Gastroparesis, Parkinson's Disease) Type and End
User Forecast to 2026
www.reportsanddata.com
2
Neurostimulation Devices Market An Overview
According to the current analysis of Reports and
Data, the Global Neurostimulation Devices Market
was valued at USD 5.59 Billion in 2019 and is
expected to reach USD 14.27 Billion by the year
2027, registering a CAGR of 12.4 .
Neurostimulator or neurostimulation is equipment
that is used for neuromodulation. The
neuromodulation process uses an implantable
medical device to alter neural activities for
therapeutic purposes. The recent emergence of
neurostimulation devices as a neural activity
modulator is a major disruptive discovery in the
healthcare sector. In line with this,
neurostimulation devices market leaders, as well
as emerging players, are developing machines that
can be used for neural activity modulation. For
instance, Medtronic, the U.S.-based medical
device company, launched Enterra II gastric
neurostimulator, a device that can be programmed
to generate mild electrical pulses for gastric
electrical stimulation to treat chronic nausea
and vomiting due to gastroparesis. Free Report
Sample _at_ https//www.reportsanddata.com/sample-enq
uiry-form/2303 Neurostimulation Devices Market
Dynamics The rising prevalence of chronic
diseases and lifestyle health disorders, unmet
needs of patients are stimulating technological
development while shifting the significant focus
of healthcare companies on the development of new
mechanisms, patent expiry, availability of
private and public funds for research, and
supportive regulatory scenario.
www.reportsanddata.com
3
These are some of the notable factors boosting
the market growth. The launch of new devices is
expected to support market growth over the coming
years. For instance, Medtronic developed its pain
neurostimulation system integrating the
FDA-approved SureScan MRI Technology, which is
engineered for patients to safely undergo an MRI
scan. The American Academy of Neurology lists
stroke as the third leading cause of death in the
U.S., with Alzheimers ranking sixth. Statistics
from reliable sources indicate that Parkinsons
affects nearly 1 million Americans annually, with
at least a minimum of 60,000 new cases being
reported annually, factors that will necessitate
the neurostimulation devices market. Of the
various types of neurostimulation devices, sacral
nerve stimulators are expected to be the
fastest-growing market segment during the
forecast period 2020-2027, with a CAGR of 13.2.
However, associated stringent government
regulation is a major challenge for the
Neurostimulation Devices market growth of this
market segment Neurostimulation Devices Market
Regional Outlook The Asia Pacific region is
expected to account for a 19.4 share of the
global neurostimulation devices market.
Developing nations such as China and India are
expected to witness high growth of the market.
Europe is anticipated to hold 30.6 of the market
share by the year 2027, with the regional segment
is expected to grow at a CAGR of 12.1 over the
forecast period.
www.reportsanddata.com
4
Prominent players in the Global Plant Growth
Regulators Market PLC, BioControl
Medical St. Jude Medical Spinal
Modulation Boston Scientific Corp. Synapse
Biomedical, Inc. Cochlear, Cyberonics,
Inc. Nevro Corp. Impact of COVID-19 on
Neurostimulation Devices Market The outbreak of
COVID-19 has impacted many aspects of business,
and the healthcare sector has been the most
affected by the crisis. The World Health
Organization has declared COVID-19 to be a global
pandemic, and the healthcare industry has to
undertake a number of emergency steps to help the
general public fight with the deadly disease.
While hospitals and clinics have been filled to
capacity, trying to help ailing patients, most
patients have been told to avoid healthcare
institutions if not faced with an utter emergency
as hospitals are highly contagious places. The
neurostimulation devices market is expected to
register a slowdown as neurological disorders are
not ailments that can prove to be immediately
life-threatening. But the market will once again
pick up its growth pace as things get back to
normal after the pandemic is finally over.
www.reportsanddata.com
5
Report Highlights Detailed overview of the
parent market Changing neurostimulation devices
market dynamics In-depth neurostimulation
devices market segmentation Historical,
present, and projected neurostimulation devices
market size in terms of volume and value Recent
neurostimulation devices market trends and
developments Competitive landscape Strategies
of key players and products offered Segments,
sub-segments, and geographical regions showing
growth prospects A neutral perspective on
neurostimulation devices market
performance Browse Complete Report _at_
https//www.reportsanddata.com/report-detail/neuro
stimulation-devices-market Neurostimulation
Devices Market Segmentation This report
forecasts revenue growth at global, regional, and
country levels to provide an analysis of market
trends in each of the sub-segments from 2017 to
2027. For the purpose of this report, Reports and
Data has segmented the Neurostimulation Devices
Market on the basis of product type, application
type, type, end-use, and region
www.reportsanddata.com
6
Product Type (Revenue, USD Million
20172027) Spinal Cord Stimulators Deep Brain
Stimulators Sacral Nerve Stimulators Vagus
Nerve Stimulators Gastric Electric
Stimulators Application Type (Revenue, USD
Million 20172027) Pain Management Epilepsy
Essential Tremor Urinary and Fecal
Incontinence Depression Dystonia Gastropares
is Parkinsons Disease Others Type (Revenue,
USD Million 20172027) Implantable External
www.reportsanddata.com
7
End-Use (Revenue, USD Million 20172027) Hospit
als/Clinics Cognitive Care Centers Research
Institutes Others Regional Outlook (Revenue in
USD Million 20172027) North
America o U.S. o Canada o Mexico Europe o German
y o France o U.K. o Spain o Benelux o Italy o Rest
of Europe Asia Pacific o China o India
www.reportsanddata.com
8
o Japan o South Korea o Taiwan o Australia o Rest
of Asia Pacific Latin America o Brazil o Argenti
na o Rest of Latin America Middle East
Africa o Saudi Arabia o South Africa o Egypt o Isr
ael o Rest of MEA
www.reportsanddata.com
9
About Us
Reports and Data is a market research and
consulting company that provides syndicated
research reports, customized research reports,
and consulting services. Our solutions purely
focus on your purpose to locate, target and
analyze consumer behavior shifts across
demographics, across industries and help clients
make a smarter business decision. We offer
market intelligence studies ensuring relevant and
fact-based research across a multiple industries
including Healthcare, Technology, Chemicals,
Power, and Energy. We consistently update our
research offerings to ensure our clients are
aware about the latest trends existent in the
market. Reports and Data has a strong base of
experienced analysts from varied areas of
expertise.
Contact US
John Watson Head of Business Development Reports
And Data Web www.reportsanddata.com Direct
Line 1-212-710-1370 E-mail sales_at_reportsanddata
.com
www.reportsanddata.com